Weikang Bio-Technology Announces Conference Call to Discuss Second Quarter Fiscal 2010 Results

HARBIN, China, Aug. 12 /PRNewswire-Asia-FirstCall/ -- Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) ("Weikang" or the "Company"), a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Tuesday, August 17, 2010 to discuss the second quarter fiscal 2010 results.

Mr. Ren Hu, Vice President of Finance of Weikang Bio-Technology will be leading the call.

To participate in the live conference call, please dial the following number fifteen minutes prior to the scheduled conference call time: 888-482-0024, international callers should dial 617- 801-9702; conference passcode is 64593584.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Tuesday, August 17, 2010 at 10:30 a.m. Eastern Time. To access the replay, dial 888-286-8010 and enter the passcode 30290121. International callers should dial 617-801-6888 and enter the same passcode.

This conference call will be broadcast live over the Internet and may be accessed by clicking on http://weikangbio.com at the investor info page. Please access the link at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software. For those unable to participate during the live broadcast, a 90-day replay will be available shortly after the call by accessing the same link.

About Weikang Bio-Technology Group Co., Inc.

Weikang Bio-Technology Group Co., Inc. is principally engaged in developing, manufacturing and distributing Traditional Chinese Medicine (TCM), and health and nutritional supplements in China, in compliance with requisite Chinese licenses and approvals. The Company is also expanding its business scope to develop, manufacture and distribute Chinese herbal extract products and GMP certified western prescription and OTC pharmaceuticals through its acquisition of Tianfang. For more information, please visit http://www.weikangbio.com .

    For more information, please contact:

    Company contact:
     Ren Hu, VP of Finance
     Weikang Bio-Technology Group Co., Inc.
     US Tel:     +1-201-887-0415
     China cell: +86-137-1872-8163
     Email:      [email protected]

    Investors Relation contacts:
     John Marco, Partner, Elite IR
     Tel:   +1-310-819-2948
     Email: [email protected]

     Leslie J. Richardson, Partner, Elite IR
     Tel:   +852-3183-0283
     Email: [email protected]

SOURCE Weikang Bio-Technology Group Co., Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED